MedTrace Logo

Efficiency of Presurgical Basal Cell Carcinoma Margin Mapping

NCT03420846 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2020-01-28

No results posted yet for this study

Summary

This Interventional Randomised Controlled study is intended to establish that presurgical margin mapping of BCCs with OCT results in a reduction of the number of MMS surgery stages without adversely impacting clinical outcome, resulting in shorter patient stays and more efficient use of surgical and operating room resources.

Conditions

  • Carcinoma, Basal Cell

Interventions

OTHER

OCT Mapped

Presurgical mapping of Basal Cell Carcinoma margins

Sponsors & Collaborators

  • Skin Care Network Ltd.

    collaborator INDUSTRY

  • Michelson Diagnostics Ltd.

    lead INDUSTRY

Principal Investigators

  • Howard Stevens · Skin Care Network Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2019-09-01
Completion
2019-09-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03420846 on ClinicalTrials.gov